HIF1A and central nervous system cancer: Traditionally, invasive methods, including oxygen electrodes and biopsy-derived techniques, have been used to assess HIF-1α expression in glioma, but have accuracies that largely depend on tissue sampling and cannot reflect the oxygenation status of the whole tumor due to the heterogeneous distribution of tumor hypoxia (6, 7).